CA
MRK icon

Crewe Advisors’s Merck MRK Stock Holding History

Crewe Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
10,490
+665
+7% +$77.8K 0.1% 75
2026
Q1 		$1.18M Buy
9,825
+141
+1% +$16.3K 0.1% 74
2025
Q4 		$1.02M Buy
9,684
+57
+0.6% +$5.35K 0.09% 83
2025
Q3 		$808K Sell
9,627
-163
-2% -$13.4K 0.08% 90
2025
Q2 		$775K Sell
9,790
-231
-2% -$18.4K 0.11% 71
2025
Q1 		$899K Sell
10,021
-235
-2% -$21.9K 0.13% 58
2024
Q4 		$1.02M Sell
10,256
-1,092
-10% -$113K 0.14% 53
2024
Q3 		$1.29M Buy
11,348
+238
+2% +$28.3K 0.15% 49
2024
Q2 		$1.38M Buy
11,110
+291
+3% +$37.5K 0.15% 59
2024
Q1 		$1.43M Buy
+10,819
New +$1.33M 0.17% 55
2023
Q3 		– Sell
-11,170
Closed -$1.29M – 800
2023
Q2 		$1.29M Buy
11,170
+100
+0.9% +$11.4K 0.18% 47
2023
Q1 		$1.18M Sell
11,070
-314
-3% -$33.9K 0.17% 49
2022
Q4 		$1.26M Buy
11,384
+411
+4% +$42K 0.2% 49
2022
Q3 		$945K Buy
10,973
+472
+4% +$42.1K 0.17% 45
2022
Q2 		$957K Buy
10,501
+1,513
+17% +$134K 0.21% 36
2022
Q1 		$737K Buy
8,988
+6,659
+286% +$525K 0.14% 39
2021
Q4 		$178K Buy
2,329
+2,204
+1,763% +$176K 0.04% 93
2021
Q3 		$9K Hold
125
– – ﹤0.01% 273
2021
Q2 		$10K Sell
125
-583
-82% -$43.4K ﹤0.01% 280
2021
Q1 		$52K Sell
708
-65
-8% -$4.79K 0.01% 149
2020
Q4 		$60K Sell
773
-140
-15% -$10.7K 0.02% 127
2020
Q3 		$72K Buy
913
+782
+597% +$61.3K 0.03% 102
2020
Q2 		$10K Hold
131
– – ﹤0.01% 161
2020
Q1 		$10K Hold
131
– – 0.01% 143
2019
Q4 		$11K Hold
131
– – ﹤0.01% 179
2019
Q3 		$11K Buy
131
+124
+1,771% +$9.94K 0.01% 179
2019
Q2 		$1K Hold
7
– – ﹤0.01% 291
2019
Q1 		$1K Buy
+7
New +$524 ﹤0.01% 236

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Crewe Advisors's MRK Position: Q2 2026 in Review

Crewe Advisors increased its Merck (MRK) stake by 6.8% in Q2 2026, buying an estimated $77.8K and bringing the position to 10,490 shares worth $1.35M. The position accounts for 0.1% of the portfolio, ranked #75.

Crewe Advisors first reported a position in MRK in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.43M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crewe Advisors held 10,490 shares of Merck worth $1.35M as of Q2 2026.
  • Crewe Advisors bought 665 Merck shares in Q2 2026, an estimated $77.8K.
  • Merck made up 0.1% of Crewe Advisors's portfolio in Q2 2026, its #75 holding.
  • Crewe Advisors first reported a position in Merck in Q1 2019 and has held it in 28 quarters since.
  • Crewe Advisors's Merck position peaked at $1.43M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.